Screen Shot 2015-02-10 at 5.32.20 PM
Table 3. Relationship between elevated shock index values and 28-day mortality from the DCLHb traumatic hemorrhagic shock clinical trials.
Table 3. Relationship between elevated shock index values and 28-day mortality from the DCLHb traumatic hemorrhagic shock clinical trials.
Table 3. Relationship between elevated shock index values and 28-day mortality from the DCLHb traumatic hemorrhagic shock clinical trials.